NVDA
186.56
-0.61%↓
AVGO.US
346.17
-1.07%↓
ORCL
194.87
-1.14%↓
MU
285.63
-2.39%↓
CSCO
77
-0.54%↓
NVDA
186.56
-0.61%↓
AVGO.US
346.17
-1.07%↓
ORCL
194.87
-1.14%↓
MU
285.63
-2.39%↓
CSCO
77
-0.54%↓
NVDA
186.56
-0.61%↓
AVGO.US
346.17
-1.07%↓
ORCL
194.87
-1.14%↓
MU
285.63
-2.39%↓
CSCO
77
-0.54%↓
NVDA
186.56
-0.61%↓
AVGO.US
346.17
-1.07%↓
ORCL
194.87
-1.14%↓
MU
285.63
-2.39%↓
CSCO
77
-0.54%↓
NVDA
186.56
-0.61%↓
AVGO.US
346.17
-1.07%↓
ORCL
194.87
-1.14%↓
MU
285.63
-2.39%↓
CSCO
77
-0.54%↓
24h
Current
Min
80.19
Max
80.56
Income | -58M 97M |
|---|---|
Sales | 5.8M 1.2B |
P/E Sector Avg | 16.085 56.104 |
Dividend yield | 2.58 |
Profit margin | 8.443 |
Employees | 26,969 |
EBITDA | -67M 186M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +22.97% upside |
Dividend yield Sector Avg | 2.58% 2.49% |
|---|---|
Next Ex Dividend date | 30 Mar 2026 |
Market Cap | -469M 8.9B |
|---|---|
Previous open | 81.47 |
Previous close | 80.47 |
By Acuity
50%
50%
126 / 403 Technology
By Trading Central
Confidence
Bullish Evidence
88.72 / N/A Support & Resistance
Past performance is not a reliable indicator of future results.
31 Dec 2025, 22:20 UTC
Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug
DJ
Read
31 Dec 2025, 17:31 UTC
OwlTing Climbs on Launch of $10 Million Stock-Buyback Program
DJ
Read
31 Dec 2025, 16:30 UTC
Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders
DJ
Read
31 Dec 2025, 15:19 UTC
Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing
DJ
Read
31 Dec 2025, 15:17 UTC
Nike Shares Rise After CEO Hill Buys $1 Million of Shares
DJ
Read
31 Dec 2025, 14:37 UTC
Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application
DJ
Read
1 Jan 2026, 23:35 UTC
Gold Rises Amid Geopolitical Risks -- Market Talk
DJ
Read
1 Jan 2026, 21:29 UTC
BlueScope: Transaction Completed on Terms Agreed When Deal Announced on Nov 13
DJ
Read
1 Jan 2026, 21:29 UTC
BlueScope Sold Stake in JV to Tata Steel
DJ
Read
1 Jan 2026, 21:28 UTC
BlueScope Steel Says Sale of Stake in Tata BlueScope Steel Completed on Dec 31
DJ
Read
1 Jan 2026, 17:20 UTC
Basic Materials Roundup: Market Talk
DJ
Read
1 Jan 2026, 09:20 UTC
Basic Materials Roundup: Market Talk
DJ
Read
31 Dec 2025, 21:50 UTC
Basic Materials Roundup: Market Talk
DJ
Read
31 Dec 2025, 21:13 UTC
10 People to Watch in Wealth Management in 2026 -- Barrons.com
DJ
Read
31 Dec 2025, 20:40 UTC
Dollar Posting Its Worst Year Since 2017 -- Market Talk
DJ
Read
31 Dec 2025, 20:22 UTC
Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk
DJ
Read
31 Dec 2025, 19:50 UTC
U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk
DJ
Read
31 Dec 2025, 19:31 UTC
Precious Metals Cap Off Record Runs -- Market Talk
DJ
Read
31 Dec 2025, 18:50 UTC
Global Equities Roundup: Market Talk
DJ
Read
31 Dec 2025, 18:50 UTC
Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk
DJ
Read
31 Dec 2025, 17:17 UTC
U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk
DJ
Read
31 Dec 2025, 17:16 UTC
OwlTing Climbs on Launch of $10M Stock-Buyback Program
DJ
Read
31 Dec 2025, 17:15 UTC
Global Commodities Roundup: Market Talk
DJ
Read
31 Dec 2025, 17:00 UTC
Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ
DJ
Read
31 Dec 2025, 15:57 UTC
Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com
DJ
Read
31 Dec 2025, 15:54 UTC
Layoff Data Supports Dollar at End of Losing Year -- Market Talk
DJ
Read
31 Dec 2025, 15:02 UTC
Nike Shares Rise After CEO Hill Buys $1M of Shares
DJ
Read
31 Dec 2025, 14:40 UTC
Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com
DJ
Read
31 Dec 2025, 14:20 UTC
Crude Futures On Track to End the Year With Losses -- Market Talk
DJ
Read
31 Dec 2025, 13:46 UTC
U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 99 USD 22.97%
High 111 USD
Low 87 USD
Based on 6 Wall Street analysts offering 12 month price targets forAmdocs Ltd - Dist in the last 3 months.
By TipRanks
Strong Buy
6 ratings
5
Buy
1
Hold
0
Sell
Based on 6 analysts giving stock ratings to Amdocs Ltd - Dist in the past 3 months.
By Trading Central
Short Term
Bullish Evidence
Bullish events outweigh bearish events.
Intermediate Term
Bullish Evidence
Recent bullish events outweigh bearish events.
Long Term
Strong Bullish Evidence
All events are bullish.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$